ABSTRACT Introduction Coronavirus Disease 2019 is a contagious infection that has
infected millions worldwide. The objective of this systematic review is to identify studies …

BACKGROUND: Antiviral medications are being given empirically to some patients with
coronavirus disease 2019 (COVID-19). To support the development of a COVID-19 …

Background Remdesivir, molnupiravir, and nirmatrelvir/ritonavir are three antiviral agents
approved by FDA emergency authorization for treating mild to moderate symptomatic COVID …

Abstract Background Coronavirus disease 2019 (COVID-19) continues to pose a significant
threat to public health worldwide. The purpose of this study was to review current evidence …

Objective To investigate the efficacy and safety of antiviral drugs in the treatment of
coronavirus disease 2019 (COVID-19). Methods All clinical trials of antiviral drug treatment …

The whole world is battling through coronavirus disease 2019 (COVID-19) which is a fatal
pandemic. In the early 2020, the World Health Organization (WHO) declared it as a global …

Methods An extensive search was performed in PubMed, EMBASE, Cochrane Library for
randomised controlled trials (RCTs), prospective case series studies that evaluated …

Background: The purpose of the current systematic review is to evaluate the efficacy of
antiviral therapies in treatment of COVID-19. In addition, clinical trials on the efficacy of …

The COVID-19 pandemic required rapid response to the needs of critically ill patients, and
one of the solutions was re-purposing of drugs with wide spectrum of antiviral action for …

Background: Randomized trial evidence suggests that some antiviral drugs are effective in
patients with COVID-19. However, the comparative effectiveness of antiviral drugs in …